Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


APT Therapeutics Inc.

Latest From APT Therapeutics Inc.

Deals Shaping The Medical Industry, February 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in January 2017

Deals BioPharmaceutical

Deal Watch: Taking Care Of Business Before J.P. Morgan

Under Momenta/CSL autoimmune partnership, Momenta can opt in to co-development or commercialization on recombinant Fc receptor modulator or just earn a revenue stream from CSL’s efforts with the preclinical candidate. Pieris and Servier sign broad-based immuno-oncology collaboration, while Arena hands off the disappointing Belviq to Eisai.

Deals Business Strategies

APT Therapeutics

Current public genomic information has dramatically simplified the identification of novel proteins. An immediate challenge exists, however, to predict the precise function of these proteins. APT Therapeutics Inc. has developed technologies to address this hurdle, with an initial goal of using these tools to prioritize candidates for preclinical validation. In addition, it has acquired significant expertise in optimization of protein expression and preclinical production.

Start-Up Previews (10/04)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups: Small Steps Forward in Treating Ischemic Stroke and Spine-Bending Market. Plus these Start-Ups across Health Care: Alveolus Inc. and BioCare Systems Inc.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • APT Therapeutics Inc.
  • Senior Management
  • R Chen, PhD, CEO
  • Contact Info
  • APT Therapeutics Inc.
    Phone: (314) 800-4742
    4041 Forest Park Ave.
    St. Louis, MO 63108